Removing sections is most of the work.
Pharmaceutical website redesign for sites that grew by accretion, where every campaign added a section, every market added a page and nothing was ever taken away. The hard part is deciding what does not survive.
Most sites we are asked to redesign do not have a visual problem, they have a structural one: three overlapping product sections, a professional area nobody can find, campaign landing pages still live four years later, and a navigation that reflects an org chart from a previous reorganisation.
A content inventory with a decision per URL, a new architecture, the redesign itself, and the technical work to preserve the visibility the current site already has.
We restructure and reduce the regulated content down to what the new architecture needs, without touching what it says, so what may be published stays a decision your team makes.
The scale a pharmaceutical website redesign has to account for before anything is drawn.
A redesign is usually driven by structural and operational needs, not appearance alone. Pharmaceutical website redesign starts from what stopped working.
What companies ask before committing to a rebuild.
Not if the URL mapping is done properly and the content that earns those positions survives the restructure. Redesigns lose visibility when pages are deleted without a destination or when the content is rewritten wholesale at the same time. Both are avoidable, and both are decisions taken at inventory stage.
Frequently, and it is worth checking before assuming otherwise. If the platform is sound and only the structure and design have aged, a redesign in place costs considerably less than a replatform. We would tell you that rather than selling the larger project.
More than most clients expect going in. It is common to find a substantial share of pages carrying no meaningful traffic, no inbound links and no internal owner responsible for them. Removing that dead weight makes what remains easier to find, both for visitors browsing the site and for search engines crawling it.
You do. We bring the data — traffic, links, duplication, last update — and a recommendation per URL. The decision on regulated and commercially sensitive content sits with your team, which is why the inventory is a working session rather than a document we send.
A redesign often arrives with a migration or a multilingual rollout attached. These are the services it most often sits with.
A site that grew past its structure, or a brand refresh with a date attached. Tell us the context and we will tell you how we would approach the pharmaceutical website redesign.